Teduglutide

Product overview
Catalog Number
PPH08-1008
Sequence
H-His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-OH
Target
Glucagon-like Peptide-2 Analog Used to Treat Short Bowel Syndrome
Description
Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome. It works by promoting mucosal growth and possibly restoring gastric emptying and secretion. In Europe it has been granted orphan drug status and is marketed under the brand Revestive by Nycomed. It was approved by the United States under the name Gattex on 21 December 2012 and also is an orphan drug there. Glucagon-like Peptide-2 Analog Used to Treat Short Bowel Syndrome. Bolar Exemption applies.This is a FDA-regulated product. It is the responsibility of the customer to ensure that they are complying with Federal rules. PI cannot be liable for infringement of rights made by the user. Trifluoroacetate. C164H252N44O55S. HGDGSFSDEMNTILDNLAARDFINWLIQTKITD. CAS 197922-42-2. Molecular Weight: 3752.16
Category
Catalog peptides, Biologically Active Peptides
Product Properties
Quantity

1mg, 5mg
Storage

Shipped at 4°C. Store at -20°C for one year.
Purity

> 95%
Source

Synthetic
Forma appearance

Lyophilized powder
  • For research use only
  • Not for use in diagnostic procedures

€405,00 – €1.655,00 Tax excluded
Contact us to request price here
Register to buy peptides
Contact us